Clinical Significance of Combined Use of Macrophage Colony-Stimulating Factor and Squamous Cell Carcinoma Antigen as a Selective Diagnostic Marker for Squamous Cell Carcinoma Arising in Mature Cystic Teratoma of the Ovary

2000 ◽  
Vol 77 (3) ◽  
pp. 405-409 ◽  
Author(s):  
Mitsuaki Suzuki ◽  
Natsuko Tamura ◽  
Hiroshi Kobayashi ◽  
Michitaka Ohwada ◽  
Toshihiko Terao ◽  
...  
Tumor Biology ◽  
2003 ◽  
Vol 24 (5) ◽  
pp. 236-240 ◽  
Author(s):  
C. Kuropkat ◽  
A.A. Dünne ◽  
S. Plehn ◽  
M. Ossendorf ◽  
U. Herz ◽  
...  

Oncology ◽  
1995 ◽  
Vol 52 (4) ◽  
pp. 287-290 ◽  
Author(s):  
Mitsuaki Suzuki ◽  
Hiroshi Kobayashi ◽  
Isao Sekiguchi ◽  
Katsuyuki Konnai ◽  
Toshihiko Terao ◽  
...  

2016 ◽  
Vol 30 (2) ◽  
pp. 122-127 ◽  
Author(s):  
Yukashi Yamashita ◽  
Takayuki Uehara ◽  
Masahiro Hasegawa ◽  
Zeyi Deng ◽  
Sen Matayoshi ◽  
...  

2021 ◽  
Vol 49 (2) ◽  
pp. 030006052098154
Author(s):  
Xiangyu Wang ◽  
Wenjing Li ◽  
Yan Kong ◽  
Xiangyu Liu ◽  
Zhumei Cui

Objective This study aimed to examine the clinicopathological characteristics, treatment, and prognostic factors in 12 cases of malignant transformation of mature cystic teratoma of the ovary (MCTO). Methods We performed a retrospective study of 12 patients with malignant transformation of MCTO who were admitted to the Affiliated Hospital of Qingdao University from 2003 to 2019. We examined case records, clinical parameters, and biological assessments. Results The median age of the patients was 56.5 years and seven of them were postmenopausal. The average tumor size was 18.5 cm. All patients had pelvic masses at their first hospital visit. Nine of the patients had discomfort in the lower abdomen, two presented with a lower abdominal palpable mass, and three were complicated by fever. The median follow-up time was 73 months (12‒193 months). Ten patients survived with a disease-free status and two died. Conclusions There is a low incidence of malignant transformation of MCTO, and its most common histological type is squamous cell carcinoma. Age and tumor size are important factors in malignant transformation of teratomas. While there is a lack of treatment guidelines for malignant transformation of MCTO, early diagnosis and treatment may be beneficial for these patients.


2012 ◽  
Vol 4 (1) ◽  
Author(s):  
Jun-ichi Kobayashi ◽  
Akihiro Miyazaki ◽  
Takashi Yamamot ◽  
Kenji Nakamori ◽  
Rina Suzuki ◽  
...  

2008 ◽  
Vol 278 (3) ◽  
pp. 287-290 ◽  
Author(s):  
Keiko Mekaru ◽  
Shigeru Kamiyama ◽  
Hitoshi Masamoto ◽  
Chiaki Yagi ◽  
Makoto Hirakawa ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document